CVD Risk Factor Management: It’s a Team Sport

Audience: CRB/Pulmonary Therapists, OT, PT
Course level: Intermediate
Continuing education contact hours: 1.0
 
All disciplines will receive a certificate of course completion.  Course will not be submitted for Approved credits through your professional organization, but you may be able to submit the hours towards your licensure.  Please see your organizations CE requirements for license and determining appropriate related courses.
 
Course is expected to be completed in full to receive a course certificate of completion.
 
Course Description:
Blood Pressure: Diagnosis and surveillance: IP, home and rehab. Also, will include when to notify providers, treatment guidelines and old and new drug options. Lipids will also be discussed and include Primary vs. Secondary, what are the treatment goals? Side effects and what role does triglycerides play?
 
Instructor(s):
Jeremy Van’t Hof is a Minnesota native who traveled to Michigan for undergraduate training in biochemistry (Calvin College) and then to California for medical school (Loma Linda University). Informing his lifelong interest in public health, he spent a key five-month period in Honduras as a rural health clinic volunteer performing rural medicine outreach. He returned to Minnesota in 2012 in order to complete an Internal Medicine Residency and Cardiovascular Medicine Fellowship at the University of Minnesota.
Dr. Van’t Hof’s clinical interests include early detection of cardiovascular disease in order to prevent or delay the onset of cardiovascular events, familial hypercholesterolemia, resistant hypertension and complex polyvascular disease. He believes in an integrative treatment approach combining lifestyle alterations with evidence based medical therapy to maximize physical and mental health as well as quality of life.
Dr. Van’t Hof’s research interest involves improving cardiovascular disease detection and early intervention. He believes that poor cardiovascular health is often a result of poor public health literacy, linked to inefficiencies created by the current “sickness-based” health care delivery system. The failure of cardiovascular prevention is a key factor that leads individuals to a less happy, less productive, and shorter life. Dr. Van’t Hof is dedicated to all efforts that improve both individual cardiovascular health and population health through public health.
 
Objectives:
Upon completion of this course, participants will be able to:
  • Identify blood pressure treatment goals.
  • Determine next steps for out of range blood pressure.
  • Recognize common anti-hypertension medications and their side effects.
  • Identify ways to educate patients on blood pressure monitoring and treatment in both     and outpatient rehab.
  • Recognize the difference in lipid lowering therapy in primary versus secondary prevention.
  • Recognize difference in statin effectiveness and identify common side effects.
  • Recognize options for lipid lowering beyond statins.
  • Identify causes for elevated triglycerides (what is significance to health if readings remain high despite treatment)
Agenda:
Blood pressure
Diagnosis and surveillance: inpatient, home, rehab
When to notify providers
Treatment: guidelines, old and new drug options
Education: where do patients receive information and what do they get
Lipids
Primary vs Secondary
-Treatment goals
-How low to go?
Treatment: old and new
Side effects
What role do triglycerides play?

 

Watch this video on Microsoft Stream  Watch 'CVD Risk Factor Management_ It’s a Team Sport-20220824_005312-Meeting Recording' | Microsoft Stream (Classic)